Peptilogics ^Companies

Peptilogics is an organization that aims to revolutionize the discovery process for novel peptide therapeutics for patients with serious and life-threatening diseases. They combine the potential of peptide biology with the power of machine learning to approach drug design at a massive scale. Peptilogics explores untapped chemical space to engineer peptides that can treat challenging diseases. They have developed an AI platform that transforms peptide drug discovery by enabling in silico predictive peptide design across diverse targets. Their goal is to design peptides with optimized properties for success as drug candidates. The potential for peptide therapeutics to treat a broad variety of diseases is significant, and Peptilogics is at the forefront of this innovative approach.